Relationship Between Expression of Cell Regulatory Factor SKP2 and Drug Resistance of HL-60/A Cells

肖洁,尹松梅,谢双锋,聂大年,李益清,马丽萍,王秀菊,冯坚红
DOI: https://doi.org/10.3321/j.issn:1672-3554.2009.02.004
2009-01-01
Abstract:【Objective】To observe the proportion of cell cycle and the expression of cell cycle regulators S-phase kinase-associated protein 2 (SKP2) and P27(superscript kip1) in drug-resistant leukemia cell line HL-60/A and drug non-resistant cell line HL-60, and to investigate the relationship between proliferation and multi-drug resistance of leukemia cells. 【Methods】The expression of SKP2, P27(superscript kip1), and multi-drug resistance associated protein (MRP) mRNA were determined by RT-PCR and Western blot analysis. The cell cycle was analyzed by flow cytometry. Drug toxicity analysis was used to determine the sensitivity of the cells to chemotherapeutic drugs. 【Results】Drug-resistant leukemia cell line HL-60 / A showed 49.14-fold resistance to Adriamycin, 39.20- fold resistance to Daunorubicin, and 6.43-fold resistance to Arabinosylcytosine, respectively. MRP expression of HL-60/A cell was higher than that of HL-60 cell. The proportions of HL-60/A cells and HL-60 cells in the G0/G1 phase of the cell cycle were (35.10±0.81)% and (43.96±1.12)%, respectively (P<0.05). The expression of SKP2 was significantly higher in HL-60/A cells than that in HL-60 cells, but the expression of P27(superscript kip1) in HL-60/A cells was lower. 【Conclusions】 The mechanism of multi-drug resistance of HL-60/A cell line is related to up-regulated expression of MRP. The proportion of drug resistant cell line HL-60/A at the proliferation stage is high which indicates that drug-resistant cells have higher proliferative activity.
What problem does this paper attempt to address?